Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Learn how synthetic promoters bring innovation to gene expression, enhancing performance and safety in biotechnology ...
New research shows epigenetic silencing may limit durability of AAV gene therapy in haemophilia by reducing long term ...
Belief BioMed (BBM) today announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially ...
Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life ...
FDA alignment achieved on pivotal study design supporting a planned Biologics License Application (BLA) submission -- 30-patient pivotal study initiated, evaluating seizure reduction and ...
Meta and YouTube were found liable for negligence in protecting a minor, with damages awarded for the psychological toll of ...
The Chinese biotech company received regulatory clearance for its BBM-H901 treatment, marking the country's inaugural gene ...
Learn how to create better AI images with six powerful Claude prompts. Turn simple ideas into detailed, high-quality visuals ...
Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection: Shanghai, China Saturday, March 21, 2026, 17:00 Hrs [IST] Belie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results